PMC8244180_01
2/2017 hypermetabolic activity within the subcarinal lymph nodes.
CRIRH2021-5529523.001.jpg
PMC8244180_01_CRIRH2021-5529523.001.jpg
fig1
Progression of her splenic involvement was also noted (see Figures 1 and 2 ).
2/2017 significant abnormal radiotracer uptake within the spleen and scattered foci of hypermetabolic activity within the liver.
CRIRH2021-5529523.002.jpg
PMC8244180_01_CRIRH2021-5529523.002.jpg
fig2
Progression of her splenic involvement was also noted (see Figures 1 and 2 ).
Low-power view showing benign liver tissue (black arrow) and granulomas (red arrow). The small red arrow shows palisading histiocytes surrounding a central fibrous area of the granuloma.
CRIRH2021-5529523.003.jpg
PMC8244180_01_CRIRH2021-5529523.003.jpg
fig3
Liver biopsy at the time showed only noncaseating granulomas with no evidence of malignancy (see Figure 3).
5/2017 interval near resolution of the bilateral hilar and subcarinal lymphadenopathy.
CRIRH2021-5529523.004.jpg
PMC8244180_01_CRIRH2021-5529523.004.jpg
fig4
PET scan showed resolution of the hilar lymphadenopathy with improvement of the left axillary and liver metabolic activity. Previously reported increased splenic and bone metabolic activity had also resolved (see Figures 4 and 5).
5/2017 the previously described diffuse scattered foci of hypermetabolic activity within the liver have significantly improved. The previously described abnormal activity within the spleen is not visualized anymore.
CRIRH2021-5529523.005.jpg
PMC8244180_01_CRIRH2021-5529523.005.jpg
fig5
PET scan showed resolution of the hilar lymphadenopathy with improvement of the left axillary and liver metabolic activity. Previously reported increased splenic and bone metabolic activity had also resolved (see Figures 4 and 5).